Skip to main content
Erschienen in: Calcified Tissue International 5/2004

01.05.2004

Weak Evidence of Thyrotropin Receptors in Primary Cultures of Human Osteoblast-like Cells

verfasst von: J. A. Tsai, A. Janson, E. Bucht, H. Kindmark, C. Marcus, A. Stark, H. Rawet Zemack, O. Torring

Erschienen in: Calcified Tissue International | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

Extra-thyroidal thyrotropin (TSH) receptors (TSHRs) have been demonstrated in several tissues and cells, including human and rat osteosarcoma cell lines. We have explored whether human TSHR (hTSHRs) also are present in primary cultures of human osteoblast-like (hOB) cells. [125 I]TSH binding was limited in hOB cells, but somewhat higher in UMR 106-01 cells and considerably higher in hTSHR-transfected CHO cells. In hOB cells, the basal intracellular cAMP levels increased 282% after stimulation with 10 U/L TSH. In the hTSHR-transfected CHO cells, the cAMP increase was 3030% in response to 10 U/L TSH and 1240% after 1 U/L TSH. Free cytoplasmic calcium did not change in response to TSH in hOB cells. HTSHR mRNA was detected in hOB cells from 3/4 bone by reverse transcriptase polymerase chain reaction RT-PCR and nucleotide sequencing HTSHR mRNA, but could not be demonstrated with the RNase protection technique in hOB cells from 5 different donors. In conclusion, even after the use of several methods, we have found only weak evidence for expression and presence of functionally active hTSHR in hOB cells. Given the low level of expression, specific binding and cAMP signaling, we suggest that it is unlikely that circulating TSH plays a physiological role for bone metabolism mediated through osteoblasts.
Literatur
1.
Zurück zum Zitat Endo, T, Ohno, M, Kotani, S, Gunji, K, Onaya, T 1993Thyrotropin receptor in non-thyroid tissues.Biochem Biophys Res Commun190774779CrossRefPubMed Endo, T, Ohno, M, Kotani, S, Gunji, K, Onaya, T 1993Thyrotropin receptor in non-thyroid tissues.Biochem Biophys Res Commun190774779CrossRefPubMed
2.
Zurück zum Zitat Nagayama, Y, Rapoport, B 1992The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning.Mol Endocrinol6145156PubMed Nagayama, Y, Rapoport, B 1992The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning.Mol Endocrinol6145156PubMed
3.
Zurück zum Zitat Smith, BR, Hall, R 1974Thyroid-stimulating immunoglobulins in Graves’ disease.Lancet2427431PubMed Smith, BR, Hall, R 1974Thyroid-stimulating immunoglobulins in Graves’ disease.Lancet2427431PubMed
4.
Zurück zum Zitat Nagayama, Y, Kaufman, KD, Seto, P, Rapoport, B 1989Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor.Biochem Biophys Res Commun16511841190PubMed Nagayama, Y, Kaufman, KD, Seto, P, Rapoport, B 1989Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor.Biochem Biophys Res Commun16511841190PubMed
5.
Zurück zum Zitat Feliciello, A, Porcellini, A, Ciullo, I, Bonavolonta, G, Avvedimento, EV, et al. 1993Expression of thyrotropin-receptor mRNA in healthy and Graves’ disease retro-orbital tissue.Lancet342337338PubMed Feliciello, A, Porcellini, A, Ciullo, I, Bonavolonta, G, Avvedimento, EV,  et al. 1993Expression of thyrotropin-receptor mRNA in healthy and Graves’ disease retro-orbital tissue.Lancet342337338PubMed
6.
Zurück zum Zitat Stadlmayr, W, Spitzweg, C, Bichlmair, AM, Heufelder, AE 1997TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves’ ophthalmopathy and pretibial myxedema.Thyroid7312PubMed Stadlmayr, W, Spitzweg, C, Bichlmair, AM, Heufelder, AE 1997TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves’ ophthalmopathy and pretibial myxedema.Thyroid7312PubMed
7.
Zurück zum Zitat Heufelder, AE, Dutton, CM, Sarkar, G, Donovan, KA, Bahn, RS 1993Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves’ ophthalmopathy and pretibial dermopathy.Thyroid3297300PubMed Heufelder, AE, Dutton, CM, Sarkar, G, Donovan, KA, Bahn, RS 1993Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves’ ophthalmopathy and pretibial dermopathy.Thyroid3297300PubMed
8.
Zurück zum Zitat Agretti, P, Chiovato, L, Marco, G, Marcocci, C, Mazzi, B, et al. 2002Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues.Eur J Endocrinol147733739PubMed Agretti, P, Chiovato, L, Marco, G, Marcocci, C, Mazzi, B,  et al. 2002Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues.Eur J Endocrinol147733739PubMed
9.
Zurück zum Zitat Marcus, C, Ehren, H, Bolme, P, Arner, P 1988Regulation of lipolysis during the neonatal period. Importance of thyrotropin.J Clin Invest8217931797PubMed Marcus, C, Ehren, H, Bolme, P, Arner, P 1988Regulation of lipolysis during the neonatal period. Importance of thyrotropin.J Clin Invest8217931797PubMed
10.
Zurück zum Zitat Janson, A, Karlsson, FA, Micha-Johansson, G, Bolme, P, Bronnegard, M 1995Effects of stimulatory and inhibitory thyrotropin receptor antibodies on lipolysis in infant adipocytes.J Clin Endocrinol Metab8017121716PubMed Janson, A, Karlsson, FA, Micha-Johansson, G, Bolme, P, Bronnegard, M 1995Effects of stimulatory and inhibitory thyrotropin receptor antibodies on lipolysis in infant adipocytes.J Clin Endocrinol Metab8017121716PubMed
11.
Zurück zum Zitat Janson, A, Rawet, H, Perbeck, L, Marcus, C 1998Presence of thyrotropin receptor in infant adipocytes.Pediatr Res43555558PubMed Janson, A, Rawet, H, Perbeck, L, Marcus, C 1998Presence of thyrotropin receptor in infant adipocytes.Pediatr Res43555558PubMed
12.
Zurück zum Zitat Inoue, M, Tawata, M, Yokomori, N, Endo, T, Onaya, T 1998Expression of thyrotropin receptor on clonal osteoblast-like rat osteosarcoma cells.Thyroid810591064PubMed Inoue, M, Tawata, M, Yokomori, N, Endo, T, Onaya, T 1998Expression of thyrotropin receptor on clonal osteoblast-like rat osteosarcoma cells.Thyroid810591064PubMed
13.
Zurück zum Zitat Tsai, JA, Bucht, E, Stark, A, Sjostedt, U, Torring, O 1998Parathyroid hormone-related protein (1-37) induces cAMP response in human osteoblast-like cells.Calcif Tissue Int62250254 Tsai, JA, Bucht, E, Stark, A, Sjostedt, U, Torring, O 1998Parathyroid hormone-related protein (1-37) induces cAMP response in human osteoblast-like cells.Calcif Tissue Int62250254
14.
Zurück zum Zitat Tsai, JA, Rong, H, Matsushita, H, Torring, O, Bucht, E 2000Interleukin-1beta upregulate PTHrP-mRNA expression and protein production and decreases TRF-β in normal human osteoblast-like cells.Calcif Tissue Int66363369 Tsai, JA, Rong, H, Matsushita, H, Torring, O, Bucht, E 2000Interleukin-1beta upregulate PTHrP-mRNA expression and protein production and decreases TRF-β in normal human osteoblast-like cells.Calcif Tissue Int66363369
15.
Zurück zum Zitat Torring, O, Firek, AF, Heath, H,3d, Conover, CA 1991Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through a adenosine 3′,5′-monophosphate-dependent mechanism.Endocrinology12810061014PubMed Torring, O, Firek, AF, Heath, H,3d, Conover, CA 1991Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through a adenosine 3′,5′-monophosphate-dependent mechanism.Endocrinology12810061014PubMed
16.
Zurück zum Zitat Sande, J, Raspe, E, Perret, J, Lejeune, C, Maenhaut, C, et al. 1990Thyrotropin activates both the cyclic AMP and the PIP2 cascades in CHO cells expressing the human cDNA of TSH receptor.Mol Cell Endocrinol74R16PubMed Sande, J, Raspe, E, Perret, J, Lejeune, C, Maenhaut, C,  et al. 1990Thyrotropin activates both the cyclic AMP and the PIP2 cascades in CHO cells expressing the human cDNA of TSH receptor.Mol Cell Endocrinol74R16PubMed
17.
Zurück zum Zitat Tsai, JA, Larsson, O, Kindmark, H 1999Spontaneous and stimulated transients in cytoplasmic free Ca2+ in normal human osteoblast-like cells: aspects of their regulation.Biochem Biophys Res Commun.206212CrossRef Tsai, JA, Larsson, O, Kindmark, H 1999Spontaneous and stimulated transients in cytoplasmic free Ca2+ in normal human osteoblast-like cells: aspects of their regulation.Biochem Biophys Res Commun.206212CrossRef
18.
Zurück zum Zitat Chomczynski, P, Sacchi, N 1987Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Anal Biochem162156159PubMed Chomczynski, P, Sacchi, N 1987Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Anal Biochem162156159PubMed
19.
Zurück zum Zitat Drvota, V, Janson, A, Norman, C, Sylven, C, Haggblad, J, et al. 1995Evidence for the presence of functional thyrotropin receptor in cardiac muscle.Biochem Biophys Res Commun211426431CrossRefPubMed Drvota, V, Janson, A, Norman, C, Sylven, C, Haggblad, J,  et al. 1995Evidence for the presence of functional thyrotropin receptor in cardiac muscle.Biochem Biophys Res Commun211426431CrossRefPubMed
20.
Zurück zum Zitat Dixon, CJ, Bowler, WB, Walsh, CA, Gallagher, JA 1997Effects of extracellular nucleotides on single cells and populations of human osteoblasts: contribution of cell heterogeneity to relative potencies.Br J Pharmacol120777780PubMed Dixon, CJ, Bowler, WB, Walsh, CA, Gallagher, JA 1997Effects of extracellular nucleotides on single cells and populations of human osteoblasts: contribution of cell heterogeneity to relative potencies.Br J Pharmacol120777780PubMed
21.
Zurück zum Zitat Hidaka, A, Minegishi, T, Kohn, LD 1993Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.Biochem Biophys Res Commun196187195CrossRefPubMed Hidaka, A, Minegishi, T, Kohn, LD 1993Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.Biochem Biophys Res Commun196187195CrossRefPubMed
22.
Zurück zum Zitat Wakasugi, M, Wakao, R, Tawata, M, Gan, N, Koizumi, K, et al. 1993Bone mineral density in patients with hyperthyroidism measured by dual energy X-ray absorptiometry.Clin Endocrinol38283286 Wakasugi, M, Wakao, R, Tawata, M, Gan, N, Koizumi, K,  et al. 1993Bone mineral density in patients with hyperthyroidism measured by dual energy X-ray absorptiometry.Clin Endocrinol38283286
23.
Zurück zum Zitat Torring, O, Tallstedt, L, Wallin, G, Lundell, G, Ljunggren, JG, et al. 1996Graves’ hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine—a prospective, randomized study. Thyroid Study Group.J Clin Endocrinol Metab8129862993PubMed Torring, O, Tallstedt, L, Wallin, G, Lundell, G, Ljunggren, JG,  et al. 1996Graves’ hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine—a prospective, randomized study. Thyroid Study Group.J Clin Endocrinol Metab8129862993PubMed
24.
Zurück zum Zitat Vestergaard, P, Mosekilde, L 2002Fracture risk in patients with hyperthyroidism and hypothyroidism: a nation-wide study of 16,249 patients.Thyroid12411419CrossRefPubMed Vestergaard, P, Mosekilde, L 2002Fracture risk in patients with hyperthyroidism and hypothyroidism: a nation-wide study of 16,249 patients.Thyroid12411419CrossRefPubMed
25.
Zurück zum Zitat Vestergaard, P, Rejnmark, L, Weeke, J, Mosekilde, L 2000Fracture risk in patients treated for hyperthyroidism.Thyroid10341348PubMed Vestergaard, P, Rejnmark, L, Weeke, J, Mosekilde, L 2000Fracture risk in patients treated for hyperthyroidism.Thyroid10341348PubMed
26.
Zurück zum Zitat Kumeda, Y, Inaba, M, Tahara, H, Kurioka, Y, Ishikawa, T, et al. 2000Persistent increase in bone turnover in Graves’ patients with subclinical hyperthyroidism.J Clin Endocrinol Metab8541574161PubMed Kumeda, Y, Inaba, M, Tahara, H, Kurioka, Y, Ishikawa, T,  et al. 2000Persistent increase in bone turnover in Graves’ patients with subclinical hyperthyroidism.J Clin Endocrinol Metab8541574161PubMed
27.
Zurück zum Zitat Bauer, DC, Nevitt, MC, Ettinger, B, Stone, K 1997Low thyrotropin levels are not associated with bone loss in older women: a prospective study.J Clin Endocrinol Metab8229312936PubMed Bauer, DC, Nevitt, MC, Ettinger, B, Stone, K 1997Low thyrotropin levels are not associated with bone loss in older women: a prospective study.J Clin Endocrinol Metab8229312936PubMed
Metadaten
Titel
Weak Evidence of Thyrotropin Receptors in Primary Cultures of Human Osteoblast-like Cells
verfasst von
J. A. Tsai
A. Janson
E. Bucht
H. Kindmark
C. Marcus
A. Stark
H. Rawet Zemack
O. Torring
Publikationsdatum
01.05.2004
Erschienen in
Calcified Tissue International / Ausgabe 5/2004
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-003-0108-3

Weitere Artikel der Ausgabe 5/2004

Calcified Tissue International 5/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.